CD8A and colorectal carcinoma: In a mouse model of CRC, Ce6-PDT was found to increase CD8 + activated T cells, CD8 + CTLs, and CD8 + naïve T cells while decreasing exhausted CD8 + T cells and CD4 + effector memory T cells.